Article: PCMD to hold workshop on Biotechnology.

Article: RIBI COMPLETES ADJUVANT LICENSE AGREEMENT FOR NEW SMITHKLINE ...
PR Newswire;  April 30, 1996 ;     700+ words ... ... covering the use of Ribi adjuvants in allergy vaccines under development by SmithKline Beecham ... regulatory approval of SB Pharma's allergy vaccines. The license is exclusive for the ... on any commercial sales of approved allergy vaccines incorporating its adjuvants. "The ...

Article: Allergy Therapeutics Ltd Presents Data on Use of Corixa's MPL(TM) ...
PR Newswire;  October 27, 1999 ;     700+ words ... ... ATL's innovative Pollinex Quattro allergy vaccines at the Allergie 2000 Symposium at ... ATL's new generation of modified allergy vaccines has demonstrated effective immunotherapy ... manufactures and sells a range of allergy vaccines for the treatment of allergies and ...

Article: ALK-Abello A/S acquires French allergy vaccines ...
Nordic Business Report;  May 27, 2005 ;     533 words ... ... REPORT-27 May 2005-ALK-Abello A/S acquires French allergy vaccines developer Allerbio SA(C)1994-2005 M2 COMMUNICATIONS ... Allerbio SA for an undisclosed sum. Allerbio develops allergy vaccines. It has 186 employees and a turnover of EUR15.7m. The ...

Article: KEEPS CANTAB DEAL; $40M ON HAND IMMULOGIC CLOSES ITS DOORS AFTER ...
BIOWORLD Today;  February 9, 1999 ;     700+ words ... ... prepared to give numbers or more details." The company, which never recovered from its failed clinical trials of the allergy vaccines Allervax Ragweed and Allervax Cat, has five employees, down from an all-time high of 155 employees two and a half years ...

Article: Dog allergy vaccines hold hope for humans Cure for ...
Chicago Sun-Times;  November 14, 2004 ;     554 words ...First in mice, now in Rover, scientists have developed vaccines that reduced or eliminated allergic reactions to peanuts, milk and wheat, offering new hope for millions who suffer from food allergies. The canine vaccines developed by a team from the Stanford University School of Medicine and the

Article: Carbohydrate-based particles are better adjuvant than alum for ...
Immunotherapy Weekly;  February 12, 2003 ;     700+ words ...2003 FEB 12 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Carbohydrate-based particles (CBP) acted as an effective adjuvant for the major timothy grass pollen allergen without causing the granulomatous tissue reaction produced by the commonly used adjuvant,

Article: Carbohydrate-based particles are better adjuvant than alum for ...
Vaccine Weekly;  February 12, 2003 ;     700+ words ...2003 FEB 12 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Carbohydrate-based particles (CBP) acted as an effective adjuvant for the major timothy grass pollen allergen without causing the granulomatous tissue reaction produced by the commonly used adjuvant,